查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1420992

移植诊断市场（筛选：移植前诊断和移植后诊断；技术：分子检测和非分子检测）- 全球产业分析、规模、份额、成长、趋势和预测，2023-2031 年

Transplant Diagnostics Market (Screening: Pre-transplant Diagnostics and Post-transplant Diagnostics; and Technique: Molecular Assay and Non-molecular Assay) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 295 Pages | 商品交期: 2-10个工作天内

价格

移植诊断市场 - 报告范围

TMR 关于全球移植诊断市场的报告研究了过去以及当前的成长趋势和机会，以获得 2023 年至 2031 年预测期内市场指标的宝贵见解。该报告提供了全球移植诊断市场的收入2017-2031年期间，考虑2023年为基准年，2031年为预测年。报告中也提供了2023年至2031年全球移植诊断市场的年复合成长率（CAGR %）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解移植诊断市场。

市场概况
2023年市场价值 12亿美元
2031 年市场价值 23亿美元
CAGR 7.7%

该报告深入探讨了全球移植诊断市场的竞争格局。全球移植诊断市场的主要参与者已经确定，并且每位参与者都已根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球移植诊断市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概述

  • 介绍
  • 概述
  • 市场动态
  • 2017-2031年全球市场分析与预测

第 5 章：关键见解

  • 管道分析
  • 主要产品/品牌分析
  • 主要併购
  • COVID-19 大流行对该行业的影响

第 6 章：全球市场分析与预测：筛选

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：按筛选，2017-2031
    • 预
    • 邮政-
  • 市场吸引力：透过筛选

第 7 章：全球市场分析与预测：依技术分类

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依技术分类，2017-2031
    • 分子检测
    • 非分子检测
    • 7.4 市场吸引力：依技术分类

第 8 章：全球市场分析与预测：按应用分类

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依应用分类，2017-2031
    • 实体器官移植
      • 肾
      • 肝
      • 心
      • 肺
      • 胰臟
      • 小肠
    • 干细胞移植
  • 市场吸引力：按应用分类

第 9 章：全球市场分析与预测：依产品与服务分类

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：按产品和服务，2017-2031
    • 试剂及耗材
    • 仪器
    • 软体与服务
  • 市场吸引力：按产品和服务分类

第 10 章：全球市场分析与预测：按最终用户

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：按最终用户，2017-2031
    • 医院及移植中心
    • 研究实验室
    • 其他的
  • 市场吸引力：按最终用户划分

第 11 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2017-2031
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力：按地区

第 12 章：北美市场分析与预测

第 13 章：欧洲市场分析与预测

第 14 章：亚太市场分析与预测

第 15 章：拉丁美洲市场分析与预测

第 16 章：中东和非洲市场分析与预测

第17章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：依公司划分（2022 年）
  • 公司简介
    • Bio-Rad laboratories, Inc.
    • Qiagen NV
    • F. Hoffmann-La Roche AG
    • Thermo Fisher Scientific, Inc.
    • Becton, Dickinson and Company
    • Ortho Clinical Diagnostics
    • Immucor, Inc.
    • Illumina, Inc.
    • Siemens Healthineers (Siemens AG)
    • Agilent Technologies
Product Code: TMRGL20225

Transplant Diagnostics Market - Scope of Report

TMR's report on the global transplant diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global transplant diagnostics market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global transplant diagnostics market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the transplant diagnostics market.

Market Snapshot
Market Value in 2023US$ 1.2 Bn
Market Value in 2031US$ 2.3 Bn
CAGR7.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global transplant diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global transplant diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global transplant diagnostics market.

The report delves into the competitive landscape of the global transplant diagnostics market. Key players operating in the global transplant diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global transplant diagnostics market profiled in this report.

Key Questions Answered in Global transplant diagnostics Market Report:

  • What is the sales/revenue generated by transplant diagnostics across all regions during the forecast period?
  • What are the opportunities in the global transplant diagnostics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Transplant Diagnostics Market - Research Objectives and Research Approach

The comprehensive report on the global transplant diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global transplant diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global transplant diagnostics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Transplant Diagnostics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Transplant Diagnostics Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Transplant Diagnostics Market Analysis and Forecast, by Screening

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Screening, 2017-2031
    • 6.3.1. Pre-transplant Diagnostics
    • 6.3.2. Post-transplant Diagnostics
  • 6.4. Market Attractiveness, by Screening

7. Global Transplant Diagnostics Market Analysis and Forecast, by Technique

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Technique, 2017-2031
    • 7.3.1. Molecular Assay
    • 7.3.2. Non-molecular Assay
    • 7.3.3. 7.4 Market Attractiveness, by Technique

8. Global Transplant Diagnostics Market Analysis and Forecast, by Application

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Application, 2017-2031
    • 8.3.1. Solid Organ Transplantation
      • 8.3.1.1. Kidney
      • 8.3.1.2. Liver
      • 8.3.1.3. Heart
      • 8.3.1.4. Lungs
      • 8.3.1.5. Pancreas
      • 8.3.1.6. Small Bowel
    • 8.3.2. Stem Cell Transplantation
  • 8.4. Market Attractiveness, by Application

9. Global Transplant Diagnostics Market Analysis and Forecast, by Products & Services

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by Products & Services, 2017-2031
    • 9.3.1. Reagents & Consumables
    • 9.3.2. Instruments
    • 9.3.3. Software & Services
  • 9.4. Market Attractiveness, by Products & Services

10. Global Transplant Diagnostics Market Analysis and Forecast, by End-user

  • 10.1. Introduction and Definitions
  • 10.2. Key Findings/Developments
  • 10.3. Market Value Forecast, by End-user, 2017-2031
    • 10.3.1. Hospitals & Transplant Centers
    • 10.3.2. Research Laboratories
    • 10.3.3. Others
  • 10.4. Market Attractiveness, by End-user

11. Global Transplant Diagnostics Market Analysis and Forecast, by Region

  • 11.1. Key Findings
  • 11.2. Market Value Forecast, by Region, 2017-2031
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness, by Region

12. North America Transplant Diagnostics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Screening, 2017-2031
    • 12.2.1. Pre-transplant Diagnostics
    • 12.2.2. Post-transplant Diagnostics
  • 12.3. Market Attractiveness, by Screening
  • 12.4. Market Value Forecast, by Technique, 2017-2031
    • 12.4.1. Molecular Assay
    • 12.4.2. Non-molecular Assay
  • 12.5. Market Attractiveness, by Technique
  • 12.6. Market Value Forecast, by Application, 2017-2031
    • 12.6.1. Solid Organ Transplantation
      • 12.6.1.1. Kidney
      • 12.6.1.2. Liver
      • 12.6.1.3. Heart
      • 12.6.1.4. Lungs
      • 12.6.1.5. Pancreas
      • 12.6.1.6. Small Bowel
    • 12.6.2. Stem Cell Transplantation
  • 12.7. Market Attractiveness, by Application
  • 12.8. Market Value Forecast, by Products & Services, 2017-2031
    • 12.8.1. Reagents & Consumables
    • 12.8.2. Instruments
    • 12.8.3. Software & Services
  • 12.9. Market Attractiveness, by Products & Services
  • 12.10. Market Value Forecast, by End-user, 2017-2031
    • 12.10.1. Hospitals & Transplant Centers
    • 12.10.2. Research Laboratories
    • 12.10.3. Others
  • 12.11. Market Attractiveness, by End-user
  • 12.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.12.1. U.S.
    • 12.12.2. Canada
  • 12.13. Market Attractiveness Analysis
    • 12.13.1. By Screening
    • 12.13.2. By Technique
    • 12.13.3. By Application
    • 12.13.4. By Products & Services
    • 12.13.5. By End-user
    • 12.13.6. By Country

13. Europe Transplant Diagnostics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Screening, 2017-2031
    • 13.2.1. Pre-transplant Diagnostics
    • 13.2.2. Post-transplant Diagnostics
  • 13.3. Market Attractiveness, by Screening
  • 13.4. Market Value Forecast, by Technique, 2017-2031
    • 13.4.1. Molecular Assay
    • 13.4.2. Non-molecular Assay
  • 13.5. Market Attractiveness, by Technique
  • 13.6. Market Value Forecast, by Application, 2017-2031
    • 13.6.1. Solid Organ Transplantation
      • 13.6.1.1. Kidney
      • 13.6.1.2. Liver
      • 13.6.1.3. Heart
      • 13.6.1.4. Lungs
      • 13.6.1.5. Pancreas
      • 13.6.1.6. Small Bowel
    • 13.6.2. Stem Cell Transplantation
  • 13.7. Market Attractiveness, by Application
  • 13.8. Market Value Forecast, by Products & Services, 2017-2031
    • 13.8.1. Reagents & Consumables
    • 13.8.2. Instruments
    • 13.8.3. Software & Services
  • 13.9. Market Attractiveness, by Products & Services
  • 13.10. Market Value Forecast, by End-user, 2017-2031
    • 13.10.1. Hospitals & Transplant Centers
    • 13.10.2. Research Laboratories
    • 13.10.3. Others
  • 13.11. Market Attractiveness, by End-user
  • 13.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.12.1. Germany
    • 13.12.2. U.K.
    • 13.12.3. France
    • 13.12.4. Italy
    • 13.12.5. Spain
    • 13.12.6. Rest of Europe
  • 13.13. Market Attractiveness Analysis
    • 13.13.1. By Screening
    • 13.13.2. By Technique
    • 13.13.3. By Application
    • 13.13.4. By Products & Services
    • 13.13.5. By End-user
    • 13.13.6. By Country/Sub-region

14. Asia Pacific Transplant Diagnostics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Screening, 2017-2031
    • 14.2.1. Pre-transplant Diagnostics
    • 14.2.2. Post-transplant Diagnostics
  • 14.3. Market Attractiveness, by Screening
  • 14.4. Market Value Forecast, by Technique, 2017-2031
    • 14.4.1. Molecular Assay
    • 14.4.2. Non-molecular Assay
  • 14.5. Market Attractiveness, by Technique
  • 14.6. Market Value Forecast, by Application, 2017-2031
    • 14.6.1. Solid Organ Transplantation
      • 14.6.1.1. Kidney
      • 14.6.1.2. Liver
      • 14.6.1.3. Heart
      • 14.6.1.4. Lungs
      • 14.6.1.5. Pancreas
      • 14.6.1.6. Small Bowel
    • 14.6.2. Stem Cell Transplantation
  • 14.7. Market Attractiveness, by Application
  • 14.8. Market Value Forecast, by Products & Services, 2017-2031
    • 14.8.1. Reagents & Consumables
    • 14.8.2. Instruments
    • 14.8.3. Software & Services
  • 14.9. Market Attractiveness, by Products & Services
  • 14.10. Market Value Forecast, by End-user, 2017-2031
    • 14.10.1. Hospitals & Transplant Centers
    • 14.10.2. Research Laboratories
    • 14.10.3. Others
  • 14.11. Market Attractiveness, by End-user
  • 14.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.12.1. China
    • 14.12.2. Japan
    • 14.12.3. India
    • 14.12.4. Australia & New Zealand
    • 14.12.5. Rest of Asia Pacific
  • 14.13. Market Attractiveness Analysis
    • 14.13.1. By Screening
    • 14.13.2. By Technique
    • 14.13.3. By Application
    • 14.13.4. By Products & Services
    • 14.13.5. By End-user
    • 14.13.6. By Country/Sub-region

15. Latin America Transplant Diagnostics Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Screening, 2017-2031
    • 15.2.1. Pre-transplant Diagnostics
    • 15.2.2. Post-transplant Diagnostics
  • 15.3. Market Attractiveness, by Screening
  • 15.4. Market Value Forecast, by Technique, 2017-2031
    • 15.4.1. Molecular Assay
    • 15.4.2. Non-molecular Assay
  • 15.5. Market Attractiveness, by Technique
  • 15.6. Market Value Forecast, by Application, 2017-2031
    • 15.6.1. Solid Organ Transplantation
      • 15.6.1.1. Kidney
      • 15.6.1.2. Liver
      • 15.6.1.3. Heart
      • 15.6.1.4. Lungs
      • 15.6.1.5. Pancreas
      • 15.6.1.6. Small Bowel
    • 15.6.2. Stem Cell Transplantation
  • 15.7. Stem Cell Transplantation Market Attractiveness, by Application
  • 15.8. Market Value Forecast, by Products & Services, 2017-2031
    • 15.8.1. Reagents & Consumables
    • 15.8.2. Instruments
    • 15.8.3. Software & Services
  • 15.9. Market Attractiveness, by Products & Services
  • 15.10. Market Value Forecast, by End-user, 2017-2031
    • 15.10.1. Hospitals & Transplant Centers
    • 15.10.2. Research Laboratories
    • 15.10.3. Others
  • 15.11. Market Attractiveness, by End-user
  • 15.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.12.1. Brazil
    • 15.12.2. Mexico
    • 15.12.3. Rest of Latin America
  • 15.13. Market Attractiveness Analysis
    • 15.13.1. By Screening
    • 15.13.2. By Technique
    • 15.13.3. By Application
    • 15.13.4. By Products & Services
    • 15.13.5. By End-user
    • 15.13.6. By Country/Sub-region

16. Middle East & Africa Transplant Diagnostics Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast, by Screening, 2017-2031
    • 16.2.1. Pre-transplant Diagnostics
    • 16.2.2. Post-transplant Diagnostics
  • 16.3. Market Attractiveness, by Screening
  • 16.4. Market Value Forecast, by Technique, 2017-2031
    • 16.4.1. Molecular Assay
    • 16.4.2. Non-molecular Assay
  • 16.5. Market Attractiveness, by Technique
  • 16.6. Market Value Forecast, by Application, 2017-2031
    • 16.6.1. Solid Organ Transplantation
      • 16.6.1.1. Kidney
      • 16.6.1.2. Liver
      • 16.6.1.3. Heart
      • 16.6.1.4. Lungs
      • 16.6.1.5. Pancreas
      • 16.6.1.6. Small Bowel
    • 16.6.2. Stem Cell Transplantation
  • 16.7. Market Attractiveness, by Application
  • 16.8. Market Value Forecast, by Products & Services, 2017-2031
    • 16.8.1. Reagents & Consumables
    • 16.8.2. Instruments
    • 16.8.3. Software & Services
  • 16.9. Market Attractiveness, by Products & Services
  • 16.10. Market Value Forecast, by End-user, 2017-2031
    • 16.10.1. Hospitals & Transplant Centers
    • 16.10.2. Research Laboratories
    • 16.10.3. Others
  • 16.11. Market Attractiveness, by End-user
  • 16.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 16.12.1. GCC Countries
    • 16.12.2. South Africa
    • 16.12.3. Rest of Middle East & Africa
  • 16.13. Market Attractiveness Analysis
    • 16.13.1. By Screening
    • 16.13.2. By Technique
    • 16.13.3. By Application
    • 16.13.4. By Products & Services
    • 16.13.5. By End-user
    • 16.13.6. By Country/Sub-region

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 17.2. Market Share Analysis, by Company (2022)
  • 17.3. Company Profiles
    • 17.3.1. Bio-Rad laboratories, Inc.
      • 17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.1.2. Product Portfolio
      • 17.3.1.3. Financial Overview
      • 17.3.1.4. SWOT Analysis
      • 17.3.1.5. Strategic Overview
    • 17.3.2. Qiagen N.V.
      • 17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.2.2. Product Portfolio
      • 17.3.2.3. Financial Overview
      • 17.3.2.4. SWOT Analysis
      • 17.3.2.5. Strategic Overview
    • 17.3.3. F. Hoffmann-La Roche AG
      • 17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.3.2. Product Portfolio
      • 17.3.3.3. Financial Overview
      • 17.3.3.4. SWOT Analysis
      • 17.3.3.5. Strategic Overview
    • 17.3.4. Thermo Fisher Scientific, Inc.
      • 17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.4.2. Product Portfolio
      • 17.3.4.3. Financial Overview
      • 17.3.4.4. SWOT Analysis
      • 17.3.4.5. Strategic Overview
    • 17.3.5. Becton, Dickinson and Company
      • 17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.5.2. Product Portfolio
      • 17.3.5.3. Financial Overview
      • 17.3.5.4. SWOT Analysis
      • 17.3.5.5. Strategic Overview
    • 17.3.6. Ortho Clinical Diagnostics
      • 17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.6.2. Product Portfolio
      • 17.3.6.3. Financial Overview
      • 17.3.6.4. SWOT Analysis
      • 17.3.6.5. Strategic Overview
    • 17.3.7. Immucor, Inc.
      • 17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.7.2. Product Portfolio
      • 17.3.7.3. Financial Overview
      • 17.3.7.4. SWOT Analysis
      • 17.3.7.5. Strategic Overview
    • 17.3.8. Illumina, Inc.
      • 17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.8.2. Product Portfolio
      • 17.3.8.3. Financial Overview
      • 17.3.8.4. SWOT Analysis
      • 17.3.8.5. Strategic Overview
    • 17.3.9. Siemens Healthineers (Siemens AG)
      • 17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.9.2. Product Portfolio
      • 17.3.9.3. Financial Overview
      • 17.3.9.4. SWOT Analysis
      • 17.3.9.5. Strategic Overview
    • 17.3.10. Agilent Technologies
      • 17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.10.2. Product Portfolio
      • 17.3.10.3. Financial Overview
      • 17.3.10.4. SWOT Analysis
      • 17.3.10.5. Strategic Overview

List of Tables

  • Table 01: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017-2031
  • Table 02: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 03: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017-2031
  • Table 04: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 05: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 06: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 07: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 08: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017-2031
  • Table 09: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 10: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 11: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017-2031
  • Table 12: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017-2031
  • Table 15: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 16: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 17: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017-2031
  • Table 18: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 19: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 20: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017-2031
  • Table 21: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 22: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 23: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017-2031
  • Table 24: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 25: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 26: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017-2031
  • Table 27: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 28: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 29: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017-2031
  • Table 30: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 31: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 32: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017-2031
  • Table 33: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 34: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 35: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017-2031
  • Table 36: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Transplant Diagnostics Market Size (US$ Mn) and Distribution (%), by Region, 2022 and 2031
  • Figure 02: Global Transplant Diagnostics Market Revenue (US$ Mn), by Screening, 2022
  • Figure 03: Global Transplant Diagnostics Market Value Share, by Screening, 2022
  • Figure 04: Global Transplant Diagnostics Market Revenue (US$ Mn), by Technique, 2022
  • Figure 05: Global Transplant Diagnostics Market Value Share, by Technique, 2022
  • Figure 06: Global Transplant Diagnostics Market Revenue (US$ Mn), by Application, 2022
  • Figure 07: Global Transplant Diagnostics Market Value Share, by Application, 2022
  • Figure 08: Global Transplant Diagnostics Market Revenue (US$ Mn), by Products & Services, 2022
  • Figure 09: Global Transplant Diagnostics Market Value Share, by Products & Services, 2022
  • Figure 10: Global Transplant Diagnostics Market Revenue (US$ Mn), by End-user, 2022
  • Figure 11: Global Transplant Diagnostics Market Value Share, by End-user, 2022
  • Figure 12: Global Transplant Diagnostics Market Value Share, by Region, 2022
  • Figure 13: Global Transplant Diagnostics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 14: Global Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
  • Figure 15: Global Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023-2031
  • Figure 16: Global Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
  • Figure 17: Global Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023-2031
  • Figure 18: Global Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 19: Global Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 20: Global Transplant Diagnostics Market Revenue (US$ Mn), by Products & Services, 2022
  • Figure 21: Global Transplant Diagnostics Market Value Share, by Products & Services, 2022
  • Figure 22: Global Transplant Diagnostics Market Revenue (US$ Mn), by End-user, 2022
  • Figure 23: Global Transplant Diagnostics Market Value Share, by End-user, 2022
  • Figure 24: Global Transplant Diagnostics Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 25: Global Transplant Diagnostics Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 26: North America Transplant Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 27: North America Transplant Diagnostics Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 28: North America Transplant Diagnostics Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 29: North America Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
  • Figure 30: North America Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
  • Figure 31: North America Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 32: North America Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031
  • Figure 33: North America Transplant Diagnostics Market Value Share Analysis, by End-user, 2023 and 2031
  • Figure 34: North America Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023-2031
  • Figure 35: North America Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023-2031
  • Figure 36: North America Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 37: North America Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023-2031
  • Figure 38: North America Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 39: Europe Transplant Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 40: Europe Transplant Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 41: Europe Transplant Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 42: Europe Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
  • Figure 43: Europe Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
  • Figure 44: Europe Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 45: Europe Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031
  • Figure 46: Europe Transplant Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 47: Europe Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023-2031
  • Figure 48: Europe Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023-2031
  • Figure 49: Europe Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 50: Europe Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023-2031
  • Figure 51: Europe Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 52: Asia Pacific Transplant Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 53: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 54: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 55: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
  • Figure 56: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
  • Figure 57: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 58: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031
  • Figure 59: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 60: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023-2031
  • Figure 61: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023-2031
  • Figure 62: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 63: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023-2031
  • Figure 64: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 65: Latin America Transplant Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 66: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 67: Latin America Transplant Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 68: Latin America Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
  • Figure 69: Latin America Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
  • Figure 70: Latin America Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 71: Latin America Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031
  • Figure 72: Latin America Transplant Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 73: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023-2031
  • Figure 74: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023-2031
  • Figure 75: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 76: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023-2031
  • Figure 77: Latin America Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 78: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 79: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 80: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 81: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
  • Figure 82: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
  • Figure 83: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 84: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031
  • Figure 85: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 86: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023-2031
  • Figure 87: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023-2031
  • Figure 88: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 89: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023-2031
  • Figure 90: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031